Cholesteryl ester transfer protein inhibitors

Details for Australian Patent Application No. 2006299557 (hide)

Owner Merck & Co., Inc.

Inventors Sinclair, Peter J.; Ali, Amjad

Agent Spruson & Ferguson

Pub. Number AU-A-2006299557

PCT Pub. Number WO2007/041494

Priority 60/722,229 30.09.05 US

Filing date 28 September 2006

Wipo publication date 12 April 2007

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/041494 Priority application(s): WO2007/041494

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299573-Improved process for analyzing, for separating, and for isolating individual polar protic monomers and/or oligomers

2006299550-Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family